Cargando…
Identification of Urine Metabolites as Biomarkers of Early Lyme Disease
Metabolites detectible in human biofluids are attractive biomarkers for the diagnosis of early Lyme disease (ELD), a vector-borne infectious disease. Urine represents an easily obtained clinical sample that can be applied for diagnostic purposes. However, few studies have explored urine for biomarke...
Autores principales: | Pegalajar-Jurado, Adoracion, Fitzgerald, Bryna L., Islam, M. Nurul, Belisle, John T., Wormser, Gary P., Waller, Kathlene S., Ashton, Laura V., Webb, Kristofor J., Delorey, Mark J., Clark, Rebecca J., Molins, Claudia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093930/ https://www.ncbi.nlm.nih.gov/pubmed/30111850 http://dx.doi.org/10.1038/s41598-018-29713-y |
Ejemplares similares
-
Biomarker selection and a prospective metabolite-based machine learning diagnostic for lyme disease
por: Kehoe, Eric R., et al.
Publicado: (2022) -
Elucidation of a Human Urine Metabolite as a Seryl-Leucine
Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy
por: Fitzgerald, Bryna L., et al.
Publicado: (2018) -
Correction to “Elucidation of a Novel Human
Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker
of Effective Anti-Tuberculosis Therapy”
por: Fitzgerald, Bryna L., et al.
Publicado: (2019) -
Elucidating the Structure of N(1)-Acetylisoputreanine:
A Novel Polyamine Catabolite
in Human Urine
por: Fitzgerald, Bryna L., et al.
Publicado: (2017) -
Autoantibodies in post-treatment Lyme disease syndrome
por: Alaedini, Armin, et al.
Publicado: (2022)